CROI 2012: The Real Life Challenge of HIV Treatment as Prevention [VIDEO]


"Treatment as prevention" was a widely referenced topic at the 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012) this month in Seattle, and has been a dominant theme in HIV/AIDS news for the past couple years. Rick Elion explains why this approach may be difficult to put into practice.

[Rick Elion, CROI 2012 interview, Seattle, March 8, 2012. Video footage courtesy of IFARA]

Data presented at last summer's International AIDS Society meeting provide definitive evidence that combination antiretroviral therapy (ART) can dramatically reduce the risk of transmitting HIV, and evidence is starting to accumulate that lowering "community viral load" can have an effect on local HIV incidence.

But the real challenge of treatment as prevention lies in achieving good adherence and ensuring that HIV positive partners maintain undetectable viral load over the long term.

Rick Elion from George Washington University School of Medicine and the Whitman Walker Clinic in Washington, DC, explains the difficulty of translating the 90% benefit seen in clinical trials into real-life use in this IFARA interview.



J Berry, C Cohen, and R Elion. CROI 2012 Antiretrovirals Panel. IFARA interview. Seattle, March 8, 2012.